Department of Pathology, University Health Network, Toronto, ON, Canada.
Brain Pathol. 2012 Jul;22(4):443-53. doi: 10.1111/j.1750-3639.2012.00599.x.
Pituitary adenomas are common neuroendocrine neoplasms arising from adenohypophysial cells. Recent progress in our understanding of pituitary tumorigenesis as well as pathways involved in molecular cytodifferentiation of the adenohypophysis has impacted on the classification of pituitary adenomas. The detailed comprehensive classification of pituitary adenomas is now well recognized to reflect specific clinical features and genetic changes that predict targeted treatments, as well as prognostic information for patients with pituitary adenomas. Therefore, the clinical responsibility of pathologists is not only limited to the distinction of pituitary adenomas from other sellar lesions, but also to provide a comprehensive subtype classification using appropriate ancillary tools. In this article, we highlight an approach to clinical diagnosis and pitfalls in the classification of these common neoplasms.
垂体腺瘤是起源于腺垂体细胞的常见神经内分泌肿瘤。近年来,我们对垂体肿瘤发生机制以及腺垂体分子细胞分化途径的认识不断深入,这对垂体腺瘤的分类产生了影响。目前,人们已经充分认识到详细的垂体腺瘤综合分类能够反映特定的临床特征和遗传改变,这些改变可以预测针对垂体腺瘤的靶向治疗,以及为垂体腺瘤患者提供预后信息。因此,病理医生的临床职责不仅限于区分垂体腺瘤与其他鞍区病变,还需要使用适当的辅助工具进行全面的亚型分类。在本文中,我们重点介绍了一种针对这些常见肿瘤的临床诊断方法和分类中的陷阱。